Loading organizations...
Loading organizations...
Biotechnology company developing innovative topical ophthalmic therapies.
Kedalion Therapeutics has raised $5.0M across 1 funding round.
Kedalion Therapeutics has raised $5.0M in total across 1 funding round.
Kedalion Therapeutics has raised $5.0M in total across 1 funding round.
Kedalion Therapeutics's investors include Mark Blumenkranz.
Kedalion Therapeutics has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Series A in August 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 6, 2018 | $5.0M Series A | Mark Blumenkranz |